IP Library Granted Patent US 10,724,106
Granted Patent B2
US 10,724,106 · App. 14/411,170 · Granted Jul 28, 2020

Method for determining the presence of diarrhoea causing pathogens

Inventors: Jenni Antikainen (Espoo, FI); Juha Kirveskari (Espoo, FI)
Assignee: MOBIDIAG OY
C12Q1/689C12Q1/6888C12Q1/6893C12Q2600/16Y02A50/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,724,106
App. No.
14/411,170
Granted
Jul 28, 2020
Kind
B2
Abstract

This invention relates to the field of detection of diarrhoea causing pathogens from patient, food or environmental samples. Particularly, the present invention provides a polymerase chain reaction (PCR) based assay method for detection of diarrhoea causing pathogens. The present invention further provides materials such as primers, primer pairs and probes for use in the method of the invention. Preferably, the method of the invention is a multiplex real-time PCR (RT-PCR) assay for rapid determination of clinically important pathogens related to traveller's diarrhoea.

Claims (224)

1. A method for determining the presence of diarrhoea causing pathogens in a biological sample comprising the steps of:

i) performing a multiplex polymerase chain reaction on the biological sample or nucleic acid isolated therefrom with multiplex primer pairs, wherein the multiplex primer pairs comprise ETEC primer pairs that amplify a nucleic acid sequence (g) of the ETEC amplicon consisting of SEQ ID NO:61, a nucleic acid sequence (h) of the ETEC amplicon consisting of SEQ ID NO:62, and a nucleic acid sequence (i) of the ETEC amplicon consisting of SEQ ID NO:63, wherein each of said multiplex primer pairs recognizes and binds to one of said ETEC amplicons consisting of SEQ ID NO:61, 62 or 63, and wherein the multiplex primer pairs comprise Campylobacter primer pairs that amplify a nucleic acid sequence (k) of the Campylobacter amplicon consisting of SEQ ID NO:65, and a nucleic acid sequence (1) of the Campylobacter amplicon consisting of SEQ ID NO:66; and

ii) detecting for amplification of the nucleic acid sequences (g), (h), (i), (k) and (l), wherein the amplification of any of the nucleic acid sequences (g), (h) and (i) is indicative of the presence of diarrhoea causing pathogen ETEC in the biological sample, and wherein the amplification of any of the nucleic acid sequences (k) and (l) is indicative of the presence of diarrhea causing pathogen Campylobacter in the biological sample.

2. The method according to claim 1 , wherein step i) further comprises primer pairs which amplify each of the Yersinia amplicons comprising SEQ ID NOS: 67-68.

3. The method according to claim 1 , wherein in step i) the sample or isolated nucleic acid therefrom is contacted with at least one ETEC primer pair selected from the group consisting of a nucleic acid sequence (g1) of at least 10 consecutive nucleotides of the sequence consisting of SEQ ID NO:13 and a nucleic acid sequence (g2) of at least 10 consecutive nucleotides of the sequence consisting of SEQ ID NO:14; a nucleic acid sequence (h1) of at least 10 consecutive nucleotides of the sequence consisting of SEQ ID NO:15 and a nucleic acid sequence (h2) of at least 10 consecutive nucleotides of the sequence consisting of SEQ ID NO:16; and a nucleic acid sequence (i1) of at least 10 consecutive nucleotides of the sequence consisting of SEQ ID NO: 17 and a nucleic acid sequence (i2) of at least 10 consecutive nucleotides of the sequence consisting of SEQ ID NO:18.

4. The method according to claim 1 , wherein said multiplex primer pairs are selected from the group consisting of a nucleic acid sequence (k1) of at least 10 consecutive nucleotides of the sequence consisting of SEQ ID NO:21 and a nucleic acid sequence (k2) of at least 10 consecutive nucleotides of the sequence consisting of SEQ ID NO:22; and a nucleic acid sequence (l1) of at least 10 consecutive nucleotides of the sequence consisting of SEQ ID NO:23 and a nucleic acid sequence (l2) of at least 10 consecutive nucleotides of the sequence consisting of SEQ ID NO:24.

5. The method according to claim 1 , wherein in step i) the sample or isolated nucleic acid therefrom is contacted with further primer pairs comprising at least one of the following sequences or a primer consisting of at least 10 contiguous nucleotides present in at least one of the following sequences:

A) forward primer:

(SEQ ID NO: 1)

5′-GCGTTCTTATGTAATGACTGCTGAAG-3′,

reverse primer:

(SEQ ID NO: 2)

5′-AGAAATTCTTCCTACACGAACAGAGTC-3′;

B) forward primer:

(SEQ ID NO: 3)

5′-TGCATCCAGAGCAGTTCTGC-3′,

reverse primer:

(SEQ ID NO: 4)

5′-CGGCGTCATCGTATACACAGG-3′;

C) forward primer:

(SEQ ID NO: 5)

5′-CCAGGCTTCGTCACAGTTGC-3′,

reverse primer:

(SEQ ID NO: 6)

5′-CAGTGAACTACCGTCAAAGTTATTACC-3′;

D) forward primer:

(SEQ ID NO: 7)

5′-GCTCTTCGGCACAAGTAATATCAAC-3′,

reverse primer:

(SEQ ID NO: 8)

5′-TCTATTTTAAATTCCGTGAAGCAAAACG-3′;

E) forward primer:

(SEQ ID NO: 9)

5′-TGGTCCATCAGGCATCAGAAGG-3′,

reverse primer:

(SEQ ID NO: 10)

5′-GGCAGTGCGGAGGTCATTTG-3′;

F) forward primer:

(SEQ ID NO: 11)

5′-TGTCTTTATAGGACATCCCTGATACTTTC-3′,

reverse primer:

(SEQ ID NO: 12)

5′-TATCTACTCTTGATGCCAGAAAACTAGC-3′;

J) forward primer:

(SEQ ID NO: 19)

5′-GGAAGCAATACATATCTTAGAAATGAACTC-3′,

reverse primer:

(SEQ ID NO: 20)

5′-TCGGACAACTGCAAGCATCTAC-3′;

M) forward primer:

(SEQ ID NO: 25)

5′-GTTTGGTACAGTTTATGGCATTTCAC-3′,

reverse primer:

(SEQ ID NO: 26)

5′-CATGGCAATATCAACAATACTCATCTTAC-3′;

N) forward primer:

(SEQ ID NO: 27)

5′-CAGGAGCATGAGGTTCACAGTATG-3′,

reverse primer:

(SEQ ID NO: 28)

5′-TCTCTGGCCCCGCACAATG-3′;

O) forward primer:

(SEQ ID NO: 29)

5′-GGGCTACAGAGATAGATATTACAGTAACTTAG-3′,

reverse primer:

(SEQ ID NO: 30)

5′-CCACGGCTCTTCCCTCCAAG-3′;

P) forward primer:

(SEQ ID NO: 31)

5′-TTCCGGTCGATCCTGCC-3′,

reverse primer:

(SEQ ID NO: 32)

5′-GTTGTCCTGAGCCGTCC-3′;

Q) forward primer:

(SEQ ID NO: 33)

5′-AGACGATCCAGTTTGTATTAG-3′,

reverse primer:

(SEQ ID NO: 34)

5′-GGCATCCTAACTCACTTAG-3′;

and

R) forward primer:

(SEQ ID NO: 35)

5′-TCTGGAAAACAATGTGTTC-3′,

reverse primer:

(SEQ ID NO: 36)

5′-GGCATGTCGATTCTAATTC-3′.

6. The method according to claim 3 , wherein the presence of the amplified target C sequence, of each of primer pairs in the PCR reaction indicates the presence of diarrhoea causing pathogens in the sample in the following way:

the product of primer pair A) or B) indicates the presence of EHEC;

the product of primer pair C) indicates the presence of EHEC/EPEC;

the product of primer pair D) indicates the presence of Salmonella;

the product of primer pair E) or F) indicates the presence of Shigella /EIEC;

the product of primer pair G), H), or I) indicates the presence of ETEC;

the product of primer pair J) indicates the presence of EAEC;

the product of primer pair K) indicates the presence of Campylobacter jejuni;

the product of primer pair L) indicates the presence of Campylobacter coli;

the product of primer pair M) indicates the presence of Yersinia enterocolitica/pseudotuberculosis;

the product of primer pair N) indicates the presence of Yersinia pseudotuberculosis/pestis;

the product of primer pair O) indicates the presence of Vibrio cholerae:

the product of primer pair P) indicates the presence of Giardia lamblia;

the product of primer pair Q) indicates the presence of Entamoeba histolytica ; and

the product of primer pair R) indicates the presence of Cryptosporidium sp.

7. The method according to claim 1 , wherein said biological sample is a stool sample or a food sample.

8. The method according to claim 5 , wherein said multiplex PCR assay is performed as a real-time polymerase chain reaction and probes consisting of at least 10 contiguous nucleotides present in the following sequences are specifically used with each of primer pairs:

the probe for primer pair A):

(SEQ ID NO: 37)

5′-TCCATGATARTCAGGCAGGACACTACTCAACCTTCC-3′,

the probe for primer pair B):

(SEQ ID NO: 38)

5′-TTGTCACTGTCACAGCAGAAGCCTTACGC-3′,

the probe for primer pair C):

(SEQ ID NO: 39)

5′-AGATTAACCTCTGCCGTTCCATAATGTTGTAACCA-3′,

the probe for primer pair D):

(SEQ ID NO: 40)

5′-CCAAACCTAAAACCAGTAAAGGCGAGCAGC-3′,

the probe for primer pair E):

(SEQ ID NO: 41)

5′-TCACTCCCGACACGCCATAGAAACGCATTT-3′,

the probe for primer pair F):

(SEQ ID NO: 42)

5′-ACAAACAGCAAAAGAGCATAGCATCCGAGAACT-3′,

the probe for primer pair G):

(SEQ ID NO: 43)

5′-CAAATATCCGTGAAACAACATGAC-3′,

the probe for primer pair H):

(SEQ ID NO: 44)

5′-AGGATTACAACACAATTCACAGCAGT-3′,

the probe for primer pair I):

(SEQ ID NO: 45)

5′-AGCAGGTTTCCCACCGGATCACCA-3′,

the probe for primer pair J):

(SEQ ID NO: 46)

5′-TCCGTATATTATCATCAGGGCATCCTTTAGGCGT-3′,

the probe for primer pair K):

(SEQ ID NO: 47)

5′-AAGACCCACAGTTTTACCAAGTTTT-3′,

the probe for primer pair L):

(SEQ ID NO: 48)

5′-AACTTGGCTCTTCTTATGTGCGT-3′,

the probe for primer pair M):

(SEQ ID NO: 49)

5′-CCTGGATAAGCGAGCGACGTATTCTCTATGC-3′,

the probe for primer pair N):

(SEQ ID NO: 50)

5′-AAACCAAAGCCGCCCACACCACAG-3′,

the probe for primer pair O):

(SEQ ID NO: 51)

5′-AACCTGCCAATCCATAACCATCTGCTGCTG-3′,

the probe for primer pair P):

(SEQ ID NO: 52)

5′-ACGAAGCCATGCATGCCCGCT-3′,

the probe for primer pair Q):

(SEQ ID NO: 53)

5′-ACAAAATGGCCAATTCATTCAATGAA-3′,

the probe for primer pair R):

(SEQ ID NO: 54)

5′-CCTCCTAATCCAGAATGTCCTCCAG-3′,

wherein the probes comprise modified nucleotides increasing melting temperature, Tm, of the probes.

9. The method according to claim 5 , wherein primer pairs A) to F) and G) to N) are in separate PCR reactions.

10. The method according to claim 5 , wherein the method comprises the following PCR reactions: the first reaction with primer pairs A) to D), the second reaction with primer pairs K) to L), the third reaction with primer pairs E), F), M), N) and O) and the fourth reaction with primer pairs P) to R).

11. The method according to claim 5 , wherein the method comprises the following PCR reactions: the first reaction with primer pairs A) to D), the second reaction with primer pairs G) to I) and K) to N), the third reaction with primer pairs E), F), J) and O) and the fourth reaction with primer pairs P) to R).

12. The method according to claim 3 , wherein the at least one ETEC primer pair comprises a primer consisting of SEQ ID NO: 13, 14, 15, 16, 17 or 18.

13. The method according to claim 12 , wherein the at least one ETEC primer pair consists of the primers consisting of SEQ ID NOS: 13 and 14.

14. The method according to claim 12 , wherein the at least one ETEC primer pair consists of the primers consisting of SEQ ID NOS: 15 and 16.

15. The method according to claim 12 , wherein the at least one ETEC primer pair consists of the primers consisting of SEQ ID NOS: 17 and 18.

16. The method according to claim 4 , wherein the at least one Campylobacter primer pair comprises a primer consisting of SEQ ID NO: 21, 22, 23 or 24.

17. The method according to claim 16 , wherein the at least one Campylobacter primer pair consists of the primers consisting of SEQ ID NOS: 21 and 22.

18. The method according to claim 16 , wherein the at least one Campylobacter primer pair consists of the primers consisting of SEQ ID NOS: 23 and 24.

19. The method according to claim 5 , wherein said multiplex PCR assay is performed as a real-time polymerase chain reaction and probes comprising the following sequences are specifically used with each of primer pairs:

the probe for primer pair A):

(SEQ ID NO: 37)

5′-TCCATGATARTCAGGCAGGACACTACTCAACCTTCC-3′,

the probe for primer pair B):

(SEQ ID NO: 38)

5′-TTGTCACTGTCACAGCAGAAGCCTTACGC-3′,

the probe for primer pair C):

(SEQ ID NO: 39)

5′-AGATTAACCTCTGCCGTTCCATAATGTTGTAACCA-3′,

the probe for primer pair D):

(SEQ ID NO: 40)

5′-CCAAACCTAAAACCAGTAAAGGCGAGCAGC-3′,

the probe for primer pair E):

(SEQ ID NO: 41)

5′-TCACTCCCGACACGCCATAGAAACGCATTT-3′,

the probe for primer pair F):

(SEQ ID NO: 42)

5′-ACAAACAGCAAAAGAGCATAGCATCCGAGAACT-3′,

the probe for primer pair G):

(SEQ ID NO: 43)

5′-CAAATATCCGTGAAACAACATGAC-3′,

the probe for primer pair H):

(SEQ ID NO: 44)

5′-AGGATTACAACACAATTCACAGCAGT-3′,

the probe for primer pair I):

(SEQ ID NO: 45)

5′-AGCAGGTTTCCCACCGGATCACCA-3′,

the probe for primer pair J):

(SEQ ID NO: 46)

5′-TCCGTATATTATCATCAGGGCATCCTTTAGGCGT-3′,

the probe for primer pair K):

(SEQ ID NO: 47)

5′-AAGACCCACCGTTTTACCAAGTTTT-3′,

the probe for primer pair L):

(SEQ ID NO: 48)

5′-AACTTGGCTCTTCTTATGTGCGT-3′,

the probe for primer pair M):

(SEQ ID NO: 49)

5′-CCTGGATAAGCGAGCGACGTATTCTCTATGC-3′,

the probe for primer pair N):

(SEQ ID NO: 50)

5′-AAACCAAAGCCGCCCACACCACAG-3′,

the probe for primer pair O):

(SEQ ID NO: 51)

5′-AACCTGCCAATCCATAACCATCTGCTGCTG-3′,

the probe for primer pair P):

(SEQ ID NO: 52)

5′-ACGAAGCCATGCATGCCCGCT-3′,

the probe for primer pair Q):

(SEQ ID NO: 53)

5′-ACAAAATGGCCAATTCATTCAATGAA-3′,

the probe for primer pair R):

(SEQ ID NO: 54)

5′-CCTCCTAATCCAGAATGTCCTCCAG-3′,

wherein the probes comprise modified nucleotides increasing melting temperature, Tm, of the probes.

Assignments (4)
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 075926/0339 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2026
From: MOBIDIAG OY
To: GEN-PROBE INCORPORATED
Reel/Frame 073553/0418 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2015
From: ANTIKAINEN, JENNI; KIRVESKARI, JUHA
To: MOBIDIAG OY
Reel/Frame 034922/0211 →
Priority Claims (1)
FI 20125730 · Jun 27, 2012 · national
Continuity (2)
Provisional Application 61664959 · Jun 27, 2012
Related Publication 20150299774A1 · Oct 22, 2015